Alba Toll

ORCID: 0000-0003-2399-5250
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Bipolar Disorder and Treatment
  • Tryptophan and brain disorders
  • Obsessive-Compulsive Spectrum Disorders
  • Mental Health Research Topics
  • Suicide and Self-Harm Studies
  • Functional Brain Connectivity Studies
  • Stress Responses and Cortisol
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Psychosomatic Disorders and Their Treatments
  • Autism Spectrum Disorder Research
  • Mental Health and Psychiatry
  • Cannabis and Cannabinoid Research
  • Attention Deficit Hyperactivity Disorder
  • Smoking Behavior and Cessation
  • Treatment of Major Depression
  • Healthcare Decision-Making and Restraints
  • Nerve injury and regeneration
  • Homicide, Infanticide, and Child Abuse
  • Cardiac Health and Mental Health
  • Genetic Associations and Epidemiology
  • Neuroscience and Neuropharmacology Research
  • Pharmaceutical studies and practices
  • Personality Disorders and Psychopathology
  • Psychiatric care and mental health services

Parc de Salut
2014-2025

Hospital Del Mar
2014-2024

Hospital del Mar Research Institute
2015-2024

Centro de Investigación Biomédica en Red de Salud Mental
2015-2024

Universitat Autònoma de Barcelona
2004-2024

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
2024

Instituto de Salud Carlos III
2024

Universitat Pompeu Fabra
2024

Hospital Universitari Germans Trias i Pujol
2024

Instituto de Neurociencias
2023

Abstract To assess the role of age (early onset psychosis-EOP < 18 years vs. adult psychosis-AOP) and diagnosis (schizophrenia spectrum disorders-SSD bipolar disorders-BD) on duration untreated psychosis (DUP) prodromal symptoms in a sample patients with first episode psychosis. 331 (7–35 old) were recruited 174 (52.6%) diagnosed SSD or BD at one-year follow-up through multicenter longitudinal study. The Symptom Onset Schizophrenia (SOS) inventory, Positive Negative Syndrome Scale...

10.1007/s00787-023-02196-7 article EN cc-by European Child & Adolescent Psychiatry 2023-04-07
Marte Z. van der Horst Yoeki Meijer Nini de Boer Sinan Gülöksüz Alkomiet Hasan and 86 more Dan Siskind Elias Wagner Cynthia Okhuijsen‐Pfeifer Jurjen J. Luykx Ahmet Müderrisoğlu Alba Toll Alde Bouhuis Alkomiet Hasan Amy Jongkind Ana González‐Pinto Anna Mané Armando D’Agostino Aygün Ertuğrul A. Elif Anıl Yağcıoğlu Benedicto Crespo‐Facorro Bianca Sánchez-Barbero Carlos Spuch Carla Lou Morgenroth Carmen Fernandez de Pinedo Cecilia Casetta Chad A. Bousman Christos Pantelis Claudia Ovejas-Catalán Clemente García‐Rizo Cynthia Okhuijsen‐Pfeifer Dan Cohen Dragana Ignjatović Ristić Edwin Beld Eila Repo‐Tiihonen Elias Wagner Ellen Jeger-Land Elisabet Vilella Erwin Bekema Stevan Sepúlveda F. Seghi Federico Wiedenmann Francesca Martini Francesca Serio Francesca Vairano Giacomo Mercuriali Giovanni Boido Gökhan Yoca Hanneke van Beek Harm J. Gijsman Heli Tuppurainen Ian Everall Ivona Novakovic Eric P. Zorrilla İbrahim Mert Erdoğan Jacopo Sapienza Jan Bogers Jari Tiihonen Javier Vázquez‐Bourgon Jim van Os Johannes Schneider‐Thoma Jurjen J. Luykx Koen P. Grootens Lorea Mar-Barrutia Lourdes Martorell Maarten Bak Marco Spangaro Marije de Vos Mariken de Koning Marina Garriga Markku Lähteenvuo Marta Bosia Marte Z. van der Horst Melih O. Babaoğlu Mike Veereschild Mirko Manchia Monika Edlinger Paloma Fuentes-Pérez Pasquale Paribello Purificación López-Peña René S. Kahn Roberto Cavallaro Selene Veerman Stefan Gutwinski Stefanie Schreiter Stephan Ripke Tania Rivera Baltanás Tatiana Oviedo-Salcedo Tero Hallikainen Thomas Görlitz Wouter Alink Yavuz Ayhan

Clozapine is often underused due to concerns about adverse drug reactions (ADRs) but studies into their prevalences are inconclusive. We therefore comprehensively examined of clozapine-associated ADRs in individuals with schizophrenia and demographic clinical factors associated occurrence. Data from a multi-center study (n=698 participants) were collected. The mean number during clozapine treatment was 4.8, 2.4% participants reporting no ADRs. most common hypersalivation (74.6%), weight gain...

10.1016/j.psychres.2023.115539 article EN cc-by Psychiatry Research 2023-10-11
Marte Z. van der Horst Nini de Boer Ahmet Müderrisoğlu Alba Toll Alde Bouhuis and 85 more Alkomiet Hasan Amy Jongkind Ana González‐Pinto Anna Mané Armando D’Agostino Aygün Ertuğrul A. Elif Anıl Yağcıoğlu Benedicto Crespo‐Facorro Bernhard T. Baune Bianca Sánchez-Barbero Carlos Spuch Carla Lou Morgenroth Carmen Fernandez de Pinedo Cecilia Casetta Chad A. Bousman Christa Hohoff Christos Pantelis Claudia Ovejas-Catalán Clemente García‐Rizo Dan Cohen Dragana Ignjatović Ristić Edwin Beld Eila Repo‐Tiihonen Elias Wagner Ellen Jeger-Land Elisabet Vilella Emilio Fernández-Egea Erwin Bekema Esteban Sepúlveda Federico Wiedenmann Francesca Martini Francesca Serio Francesca Vairano Giacomo Mercuriali Giovanni Boido Gökhan Yoca Hanneke van Beek Harm J. Gijsman Heli Tuppurainen Ian Everall Ivona Novakovic Eric P. Zorrilla İbrahim Mert Erdoğan Jacopo Sapienza Jan Bogers Jari Tiihonen Javier Vázquez‐Bourgon Jim van Os Johannes Schneider‐Thoma Jurjen J. Luykx Koen P. Grootens Lorea Mar-Barrutia Lourdes Martorell Maarten Bak Marco Spangaro M. Zierhut Marije de Vos Mariken de Koning Marina Garriga Markku Lähteenvuo Marta Bosia Marte Z. van der Horst Melih O. Babaoğlu Mike Veereschild Mirko Manchia Mishal Qubad Monika Edlinger Paloma Fuentes-Pérez Pasquale Paribello Purificación López-Peña René S. Kahn Robert A. Bittner Roberto Cavallaro Selene Veerman Stefan Gutwinski Stefanie Schreiter Stephan Ripke Tania Rivera Baltanás Tatiana Oviedo-Salcedo Tero Hallikainen Thomas Görlitz Wouter Alink Yavuz Ayhan Cynthia Okhuijsen‐Pfeifer Jurjen J. Luykx

Clozapine is highly effective for treatment-resistant schizophrenia but underutilized due to patient and clinician-related concerns. Little known about the general level of satisfaction with clozapine determinants thereof. We therefore explored in individuals diagnosed spectrum disorders (SSDs). Cross-sectional data from 480 users were used examine demographic clinical factors, including symptom severity, treatment response, adverse drug reactions (ADRs). Patient was self-rated on a scale 1...

10.1038/s41537-025-00570-9 article EN cc-by-nc-nd Schizophrenia 2025-02-23

Although there is scientific evidence of the presence immunometabolic alterations in major depression, not all patients present them. Recent studies point to association between an inflammatory phenotype and certain clinical symptoms with depression. The objective our study was classify depression disorder using supervised learning algorithms or machine learning, based on oxidative stress biomarkers lifestyle habits.

10.1016/j.pnpbp.2022.110674 article EN cc-by-nc-nd Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022-11-01

Little is known about genetic predisposition to relapse. Previous studies have linked cognitive and psychopathological (mainly schizophrenia bipolar disorder) polygenic risk scores (PRS) with clinical manifestations of the disease. This study aims explore potential role PRS from major mental disorders cognition on 114 patients recruited in 2EPs Project were included (56 who had not experienced relapse after 3 years enrollment 58 relapsed during 3-year follow-up). for (PRS-SZ), disorder...

10.1016/j.euroneuro.2023.06.003 article EN cc-by-nc-nd European Neuropsychopharmacology 2023-08-19

Introduction Thyroid hormones play an essential role in hippocampal development, a key structure psychosis. However, the of these first-episode psychosis (FEP) has received limited attention. It been hypothesized that thyroid could cause morphological modifications through upregulation brain-derived neurotrophic factor (BDNF). In this study, we primarily aimed to determine relationship between thyroid-stimulating hormone (TSH) levels, peripheral BDNF and volume antipsychotic-naïve FEP...

10.3389/fpsyt.2023.1301714 article EN cc-by Frontiers in Psychiatry 2023-12-07

Clinical intervention in early stages of psychotic disorders is crucial for the prevention severe symptomatology trajectories and poor outcomes. Genetic variability studied as a promising modulator prognosis, thus novel approaches considering polygenic nature these complex phenotypes are required to unravel mechanisms underlying progression disorder.The sample comprised 233 first-episode psychosis (FEP) subjects with clinical cognitive data assessed periodically 2-year period 150 matched...

10.1017/s0033291722001544 article EN cc-by Psychological Medicine 2022-06-09

Introduction: Negative symptoms (NS) include asociality, avolition, anhedonia, alogia, and blunted affect are linked to poor prognosis. It has been suggested that they reflect two different factors: diminished expression (EXP) (blunted alogia) amotivation/pleasure (MAP) (anhedonia, asociality). The aim of this article was examine potential sex differences among first-episode schizophrenia (FES) patients analyze sex-related predictors NS factors (EXP MAP) functional outcome. Material Methods:...

10.1016/j.sjpmh.2023.04.001 article EN cc-by-nc-nd Spanish Journal of Psychiatry and Mental Health 2023-09-01

A multicentre, non-randomised, open-label study assessed whether personal distress caused by erectile dysfunction (ED) affected psychosocial outcomes of tadalafil treatment. Eligible Swedish men at least 18 years old reporting ≥3-month history ED were stratified into two groups (manifest or mild/no distress) based upon a question administered enrolment. Tadalafil 20 mg was taken as needed for 8 weeks. The primary outcome the difference between in change from baseline Psychological and...

10.1111/j.1742-1241.2006.01171.x article EN International Journal of Clinical Practice 2006-10-11

Emotional intelligence (EI) and neurocognition (NC) impairments are common in first-episode psychosis (FEP), yet their evolution over time remains unclear. This study identified patient profiles EI NC performance FEP. 98 adult FEP patients 128 healthy controls (HCs) were tested on clinical, functional, EI, variables at baseline two-year follow-up (FUP). A repeated-measures ANOVA compared the effects of group (patients HCs) EI. Significant improvements observed both groups. Four groups...

10.1016/j.euroneuro.2024.05.006 article EN cc-by European Neuropsychopharmacology 2024-07-15

There is high prevalence of cigarette smoking in individuals with first-episode psychosis (FEP) prior to onset. The purpose the study was determine impact previous tobacco use or without cannabis on first psychotic experiences FEP and this age onset symptoms, including prodromes. Retrospective analyses from naturalistic, longitudinal, multicentre, "Phenotype-Genotype Environmental Interaction. Application a Predictive Model First Psychotic Episodes (PEPs)" Study. authors analysed...

10.1016/j.schres.2021.07.017 article EN cc-by-nc-nd Schizophrenia Research 2021-08-05
Coming Soon ...